Why the study?
Does Carbohydrate antigen 125 (CA125) measurement improve risk stratification in patients with heart diseases?
Population
Patients with heart diseases including pericarditis, atrial fibrillation, heart failure, and coronary artery…
Design
Review
Authors
Loading...
CA125 may aid congestion monitoring across cardiac conditions; leaves open its role in routine risk stratification.
Does Carbohydrate antigen 125 (CA125) measurement improve risk stratification in patients with heart diseases?
CA125 is a promising biomarker for monitoring congestion and inflammation, and for risk stratification in various heart diseases.
Falcão et al. (2018) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: